10-Q: Horizon Technology Finance Corp Reports Mixed Second Quarter Results Amidst Portfolio Adjustments

Horizon Technology Finance Corp reports a net decrease in net assets for the second quarter of 2024, influenced by unrealized depreciation on investments, despite a decrease in operating expenses.

Summary

• Horizon Technology Finance Corp reported a net decrease in net assets resulting from operations of $0.5 million for the six months ended June 30, 2024, compared to a net increase of $5.5 million for the same period in 2023.
• The company's total investment income for the six months ended June 30, 2024 was $51.8 million, a decrease from $56.2 million in the same period of 2023.
• Net investment income for the six months ended June 30, 2024 was $25.5 million, down from $29.1 million in the same period of 2023.
• The company experienced a net unrealized depreciation on investments of $28.5 million for the six months ended June 30, 2024, compared to $6.9 million for the same period in 2023.
• The company's net asset value per common share decreased to $9.12 as of June 30, 2024, from $9.71 as of December 31, 2023.
• The company's weighted average shares outstanding were 34.5 million for the six months ended June 30, 2024, compared to 29.0 million for the same period in 2023.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with decreased income and net asset value, offset by reduced expenses and a capital raise. The negative aspects outweigh the positives, leading to a slightly negative sentiment.

Positives

• The company's operating expenses decreased by $1.2 million for the six months ended June 30, 2024 compared to the same period in 2023.
• The company's base management fee expense decreased by $0.2 million for the six months ended June 30, 2024 compared to the same period in 2023.
• The company's incentive fee expense decreased by $2.8 million for the six months ended June 30, 2024 compared to the same period in 2023 due to the Incentive Fee Cap and Deferral Mechanism.

Negatives

• The company's net investment income decreased to $25.5 million for the six months ended June 30, 2024, from $29.1 million for the same period in 2023.
• The company experienced a net unrealized depreciation on investments of $28.5 million for the six months ended June 30, 2024.
• The company's net asset value per common share decreased to $9.12 as of June 30, 2024, from $9.71 as of December 31, 2023.
• The company's total investment income for the six months ended June 30, 2024 was $51.8 million, a decrease from $56.2 million in the same period of 2023.

Risks

• The company's portfolio companies may experience variation in operating results and may need additional capital to service their debt.
• The company's borrowers may be affected by changes in government regulations.
• The company's investments are subject to legal and other restrictions on resale or are less liquid than publicly traded securities.
• The company's investments are subject to market risk, including changes in interest rates.
• The company's net income is dependent upon the difference between the rate at which it borrows funds and the rate at which it invests the funds borrowed.
• Persistent inflationary pressures could affect the company's portfolio companies profit margins.

Future Outlook

The company expects to raise additional equity and debt capital opportunistically as needed and, subject to market conditions, to support its future growth to the extent permitted by the 1940 Act. The company believes that its current cash, cash generated from operations, and funds available from its Credit Facilities will be sufficient to meet its working capital and capital expenditure commitments for at least the next 12 months.

Industry Context

The company operates in the specialty finance sector, focusing on lending to development-stage companies in technology, life science, healthcare information and services, and sustainability industries. The company's performance is influenced by the overall economic environment, interest rate fluctuations, and the performance of its portfolio companies. The company's results are also affected by the availability of capital and the competitive landscape within the specialty finance sector.

Comparison to Industry Standards

• The company's performance is compared to other Business Development Companies (BDCs) that focus on venture lending. Competitors include Hercules Capital, Inc. (HTGC), and Trinity Capital Inc. (TRIN).
• The company's net investment income and net asset value per share are key metrics used to assess its performance against industry benchmarks.
• The company's portfolio turnover ratio of 5.4% for the six months ended June 30, 2024, is a measure of its investment activity compared to industry averages.
• The company's weighted average credit rating of 3.1 for its debt investments is a measure of its portfolio risk compared to industry standards.
• The company's use of leverage and its compliance with the 150% asset coverage test are compared to other BDCs.

Related Party Transactions

• The company has an Investment Management Agreement with Horizon Technology Finance Management LLC (the Advisor), under which the Advisor manages the day-to-day operations of, and provides investment advisory services to, the Company.
• The company has an Administration Agreement with the Advisor to provide administrative services to the Company.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net asset value per share and the net decrease in net assets resulting from operations.
• Employees may be affected by any changes in the company's financial performance.
• Customers (portfolio companies) may be affected by any changes in the company's lending policies or investment strategy.
• Creditors may be affected by any changes in the company's financial condition or ability to repay its debt.

Next Steps

• The company will continue to monitor its portfolio companies and their performance.
• The company will continue to evaluate new investment opportunities.
• The company will continue to manage its capital structure and liquidity.
• The company will continue to monitor the impact of economic conditions and interest rate fluctuations on its business.

Key Dates

Keywords

venture lending, debt investments, technology, life science, healthcare, sustainability, business development company, BDC, net asset value, unrealized depreciation, interest income, warrants